%PDF-1.4
%
46 0 obj
<>
endobj
111 0 obj
<>/Font<>>>/Fields[]>>
endobj
43 0 obj
<>
endobj
25 1 obj
<>stream
Acrobat Distiller 4.05 for Macintosh
2004-12-14T16:41:02Z
2024-03-28T15:41:45-07:00
QuarkXPressª: AdobePS 8.6 (219)
2024-03-28T15:41:45-07:00
application/pdf
Heather
2001-842.oct02
uuid:e624208f-1dd1-11b2-0a00-0b09271d5700
uuid:e6242094-1dd1-11b2-0a00-bf0000000000
endstream
endobj
32 0 obj
<>
endobj
33 0 obj
<>
endobj
47 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
1 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
4 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
7 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
10 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
13 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
16 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
19 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
22 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
148 0 obj
[152 0 R]
endobj
149 0 obj
<>stream
1 g
/GS0 gs
0 792 m
0 792 l
f
q
-1 793 614 -794 re
W n
q
0 792.06 612 -792 re
W n
/CS0 cs 0 0 0 0 scn
/GS1 gs
427 777 130 -27 re
f*
/CS0 CS 0 0 0 1 SCN
54 54 m
558 54 l
S
BT
0 0 0 1 scn
/TT0 1 Tf
0.02499 Tw 8 0 0 8 420.9531 35.9844 Tm
[(The Journal of Rheumatology 2002; 29:1)74 (1)]TJ
0 Tw -45.8691 -0.0313 Td
(2434)Tj
ET
0 0 0 0 scn
/GS0 gs
102.25 59.75 407.5 -10.83 re
f*
0.5 w
102.25 59.75 407.5 -10.83 re
S
BT
0 0 0 1 scn
/GS1 gs
/TT1 1 Tf
0.02499 Tw 8 0 0 8 57 714.5293 Tm
[(56.)-875 (Raczynski JM, DiClemente RJ. )17.8 (The importance of health )]TJ
2.175 -1.25 Td
(promotion and disease prevention. In: Raczynski JM, DiClemente)Tj
0 -1.25 TD
(RJ, editors. Handbook of health promotion and disease prevention.)Tj
-0.0119 Tw T*
[(New Y)100.1 (ork: )-36.8 (Kluwer )18 (Academic/Plenum; )-36.9 (1999:3-9.)]TJ
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(57.)-875.1 (Charles ST)73.9 (, Gatz M, Pederson NL, Dahlber)17.7 (g L. Genetic and)]TJ
2.175 -1.25 Td
(behavioral risk factors for self-reported joint pain among a )Tj
T*
(population-based sample of Swedish twins. Health Psychol)Tj
0 Tc 0 Tw T*
(1999;18:644-54.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(58.)-875.1 (Menefee LA, Frank ED, Doghramji K, et al. Self-reported sleep)]TJ
0 Tc 2.175 -1.25 Td
(quality and quality of life for individuals with chronic pain )Tj
T*
(conditions. Clin J Pain 2000;16:290-7.)Tj
-2.175 -1.25 Td
[(59.)-875 (Harding SM. Sleep in fibromyalgia patients: subjective and )]TJ
2.175 -1.25 Td
[(objective findings. )54.9 (Am J Med Sci 1998;315:367-76.)]TJ
-2.175 -1.25 Td
[(60.)-875 (Buchwald D, Pasqualy R, Bombardier C, Kith P)110.8 (.)0.1 ( Sleep disorders in)]TJ
2.175 -1.25 Td
(patients with chronic fatigue. Clin Infect Dis 1994;18 Suppl 1:)Tj
-0.00011 Tc 0 Tw T*
(S68-72.)Tj
0 Tc 0.02499 Tw -2.175 -1.25 Td
[(61.)-875 (Zarcone )17.8 (VP)-238.1 (Jr)54.9 (. Sleep hygiene. In: Kryger MH, Roth )17.8 (T)74 (, Dement)]TJ
2.175 -1.25 Td
(WC, editors. Principles and practice of sleep medicine. 2nd ed.)Tj
T*
[(Philadelphia: )17.8 (WB Saunders; 1994:542-6.)]TJ
-0.00011 Tc -2.175 -1.25 Td
[(62.)-875.1 (Morin CM, Culbert JP)110.7 (, Schwartz SM. Nonpharmacological)]TJ
0 Tc 2.175 -1.25 Td
[(interventions for insomnia: a meta-analysis of treatment ef)17.8 (ficacy)64.9 (.)]TJ
T*
[(Am J Psychiatry 1994;151:1)36.9 (172-80.)]TJ
-0.00011 Tc -2.175 -1.25 Td
[(63.)-875.1 (Clark SR, Jones KD, Burckhardt CS, Bennett RM. Exercise for)]TJ
2.175 -1.25 Td
(patients with fibromyalgia risks versus benefits. Curr Rheumatol)Tj
0 Tc T*
(Rep 2001;3:135-46.)Tj
-0.00011 Tc -0.0298 Tw 30.825 30 Td
[(64.)-875.1 (Hajeer AH, )-54.8 (MacGregor AJ, )-54.8 (Rigby AS, )-54.8 (Ollier )-37.1 (WE, )-54.9 (Carthy )-54.9 (D,)]TJ
0.02499 Tw 2.175 -1.25 Td
[(Silman )54.8 (AJ. Influence of previous exposure to human parvovirus)]TJ
0 Tc T*
(B19 infection in explaining disease susceptibility to rheumatoid)Tj
-0.00011 Tc T*
[(arthritis: an analysis of disease discordant twin pairs. )54.8 (Ann Rheum)]TJ
0 Tc T*
(Dis 1994;53:137-9.)Tj
-2.175 -1.25 Td
[(65.)-875 (Cicuttini FM, Baker JR, Spector )17.8 (TD. )17.8 (The association of obesity)]TJ
2.175 -1.25 Td
[(with osteoarthritis of the hand and knee in women: a twins study)64.9 (. )]TJ
T*
(J Rheumatol 1996;23:1221-6.)Tj
-2.175 -1.25 Td
[(66.)-875 (Soppi E, Eskola J, Lehtonen )54.9 (A. Evidence against HLA)-220.1 (and)]TJ
2.175 -1.25 Td
(immunological dependence of disease outbreak in SLE.)Tj
T*
(Immunological characterization of identical twins clinically )Tj
T*
[(discordant for SLE. )54.8 (Ann Rheum Dis 1985;44:45-9.)]TJ
-0.00011 Tc -2.175 -1.25 Td
[(67.)-875.1 (MacGregor )54.7 (AJ, Grif)17.7 (fiths GO, Baker J, Spector )17.6 (TD. Determinants of)]TJ
0 Tc 2.175 -1.25 Td
(pressure pain threshold in adult twins: evidence that shared)Tj
T*
(environmental influences predominate. Pain 1997;73:253-7.)Tj
-0.00011 Tc -2.175 -1.25 Td
[(68.)-875.1 (Michalowicz BS, Pihlstrom BL, Hodges JS, Bouchard )17.6 (TJ Jr)54.8 (. No)]TJ
0 Tc 2.175 -1.25 Td
(heritability of temporomandibular joint signs and symptoms. J Dent)Tj
T*
(Res 2000;79:1573-8.)Tj
-2.175 -1.25 Td
[(69.)-875 (Bengtsson B, )17.7 (Thorson J. Back pain: a study of twins. )54.8 (Acta Genet)]TJ
2.175 -1.25 Td
(Med Gemellol \(Roma\) 1991;40:83-90.)Tj
ET
Q
Q
q
0 0 612 792 re
W n
BT
0 g
/GS2 gs
/T1_0 8 Tf
120.092 51 Td
(Personal non-commercial use only. The Journal of Rheumatology Copyright\
\251 2002. All rights reserved.)Tj
ET
Q
BT
0 g
/GS2 gs
/T1_1 1 Tf
10 0 0 10 540 17 Tm
( )Tj
0 0.48627 0.77255 rg
/GS2 gs
-7.22298 0 Td
(www.jrheum.org)Tj
0 g
/GS2 gs
-16.72996 0 Td
(Downloaded on March 28, 2024 from )Tj
ET
endstream
endobj
90 0 obj
<>
endobj
119 0 obj
<>
endobj
51 0 obj
<>
endobj
57 0 obj
<>
endobj
56 0 obj
<>
endobj
85 0 obj
<>stream
HtVPTιwwYQAD`WV(b\pDX+W
VB}GRԉ5Tnd@M46DmN:F